America Continues To Unite Behind Access To Medical Marijuana, As Florida Steps In Line As The Latest State To Submit A Bill To Pass A Legal Medical Marijuana Regime, Opening More Doors For Phytiva Brand
DALLAS, March 1, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product line is very pleased that Florida has taken this action toward providing safe access to medical marijuana for its people, as the country unites behind legalization on a step by step, state by state basis. The Florida bill, "The Cathy Jordan Medical Cannabis Act," introduced on Wednesday, is named after a Florida woman with Lou Gehrig's disease who found cannabis to be her preferred treatment for severe pain. Seventy percent of Floridians support access to medical marijuana.
The medical marijuana industry continues to evolve and grow, expanding people's opportunities across the country to access critical cannabinoid-based ailment formulations made possible by the medically significant cannabinoids found in the cannabis plant. This incremental legalization of medical marijuana in the U.S. seems to be accelerating with new vigor. More states are now joining in than ever before, recognizing the value of medical marijuana for patients who need safe and legal access for treatment of their ailments.
"This is clearly a positive development for medical patients. It is also a tremendous opportunity for X-Change Corp., as the Company prepares its strategy for entering an ever-expanding market for its Phytiva brand in providing formulations to help patients across the country. The Company intends to enter all available markets, both domestically and internationally, with its Phytiva brand product lines," stated Chad Johnson, General Counsel & COO of X-Change Corp.
Florida is the most recent state in which legislators have submitted a bill to pass a medical marijuana law. Other states considering cannabis-related measures include Alabama, Arkansas, Hawaii, Iowa, Kentucky, Idaho, Maine, Maryland, Michigan, New Hampshire, Nevada, North Carolina, Oklahoma, Rhode Island, and West Virginia. The Company is monitoring developments in these important states, while it continues to focus its strategic planning and alliances in all states and jurisdictions where the Company can currently operate and conduct business with full legal authority in providing its formulations to medical patients.About The X-Change Corporation
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts